NCT01141842

Brief Summary

Some groups reported that sniffer dogs can be applied to detect lung cancer in the exhaled breath of patients. Therefore, breath samples (BS) of patients are collected. Five sniffer dogs are trained to distinguish between the BS of patients with lung cancer and healthy individuals (controls). In a prospective, randomized blinded study the dog's ability to differentiate between BS of i) patients with lung cancer, ii) patients with inflammatory airway disease, but no evidence of cancer and iii) healthy individuals is tested.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for phase_1 lung-cancer

Timeline
Completed

Started Nov 2009

Shorter than P25 for phase_1 lung-cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 11, 2010

Completed
Last Updated

May 7, 2013

Status Verified

May 1, 2013

Enrollment Period

6 months

First QC Date

May 11, 2010

Last Update Submit

May 6, 2013

Conditions

Keywords

lung cancerexhalation analysischronic obstructive pulmonary diseasecancer screening test

Outcome Measures

Primary Outcomes (1)

  • presence of an heretofore unknown substrate in the exhalation sample of a patient with confirmed lung cancer

    number of individuals in the study cohort with confirmed lung cancer whose exhalation sample is correctly identified by sniffer dogs to contain an heretofore unknown substrate that is associated with lung cancer

    baseline

Secondary Outcomes (1)

  • absence of an heretofore unknown substrate that is associated with lung cancer in patients with lung disease but excluded lung cancer

    baseline

Study Arms (3)

lung cancer

EXPERIMENTAL

breath samples of patients with confirmed lung cancer

Procedure: exhalation analysis of breath sample

underlying lung disease

ACTIVE COMPARATOR

patients with underlying lung disease and impairment in lung function

Procedure: exhalation analysis of breath sample

healthy individual

SHAM COMPARATOR

healthy individual with no lung disease and no history of cancer including lung cancer

Procedure: exhalation analysis of breath sample

Interventions

breath sample is presented to sniffer dog in test tube

lung cancer

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-80
  • competent
  • confirmed lung cancer

You may not qualify if:

  • history of other cancers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Schillerhoehe Hospital

Gerlingen, 70839, Germany

Location

Praxis Heimann & Ehmann

Stuttgart, 70178, Germany

Location

Related Publications (2)

  • Boedeker E, Friedel G, Walles T. Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening. Interact Cardiovasc Thorac Surg. 2012 May;14(5):511-5. doi: 10.1093/icvts/ivr070. Epub 2012 Feb 17.

    PMID: 22345057BACKGROUND
  • Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18.

MeSH Terms

Conditions

Lung NeoplasmsPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Thorsten Walles, MD

    Schillerhoehe Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 11, 2010

First Posted

June 11, 2010

Study Start

November 1, 2009

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

May 7, 2013

Record last verified: 2013-05

Locations